A new trading day began on Friday, with Cg Oncology Inc (NASDAQ: CGON) stock price up 3.19% from the previous day of trading, before settling in for the closing price of $29.11. CGON’s price has ranged from $25.77 to $50.23 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -45.67% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged -13.56%. With a float of $42.10 million, this company’s outstanding shares have now reached $67.54 million.
In an organization with 61 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 97.81%, operating margin of -13969.15%, and the pretax margin is -10578.22%.
Cg Oncology Inc (CGON) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Cg Oncology Inc is 37.74%, while institutional ownership is 61.80%. The most recent insider transaction that took place on Dec 16 ’24, was worth 19,600,000. In this transaction Director of this company sold 700,000 shares at a rate of $28.00, taking the stock ownership to the 3,003,931 shares. Before that another transaction happened on Dec 16 ’24, when Company’s Director sold 1,000 for $28.84, making the entire transaction worth $28,840. This insider now owns 0 shares in total.
Cg Oncology Inc (CGON) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.38 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -13.56% per share during the next fiscal year.
Cg Oncology Inc (NASDAQ: CGON) Trading Performance Indicators
Here are Cg Oncology Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 35.32. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3470.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.28, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.83 in one year’s time.
Technical Analysis of Cg Oncology Inc (CGON)
Let’s dig in a bit further. During the last 5-days, its volume was 0.88 million. That was better than the volume of 0.67 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 62.04%. Additionally, its Average True Range was 1.76.
During the past 100 days, Cg Oncology Inc’s (CGON) raw stochastic average was set at 22.57%, which indicates a significant decrease from 36.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.86% in the past 14 days, which was higher than the 47.89% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $33.98, while its 200-day Moving Average is $35.00. However, in the short run, Cg Oncology Inc’s stock first resistance to watch stands at $30.82. Second resistance stands at $31.61. The third major resistance level sits at $32.72. If the price goes on to break the first support level at $28.92, it is likely to go to the next support level at $27.81. The third support level lies at $27.02 if the price breaches the second support level.
Cg Oncology Inc (NASDAQ: CGON) Key Stats
With a market capitalization of 2.36 billion, the company has a total of 76,038K Shares Outstanding. Currently, annual sales are 200 K while annual income is -48,610 K. The company’s previous quarter sales were 40 K while its latest quarter income was -20,410 K.
